Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Working as a gynaecological surgeon

Dr John Kirawan - Liverpool Women's Hospital, UK
Working as a gynaecological surgeon ( Dr John Kirawan - Liverpool Women's Hospital, UK )
13 Feb 2013

Becoming a surgery and professor of oncology

Prof Curt Burger - Erasmus University, Rotterdam, Netherlands
Becoming a surgery and professor of oncology ( Prof Curt Burger - Erasmus University, Rotterdam, Netherlands )
12 Feb 2013

Recent advances in multiple myeloma, featuring Educational Updates from ASH 2012

Professor Gareth Morgan, Prof Roman Hajek, Dr María-Victoria Mateos, Prof Hartmut Goldschmidt
Recent advances in multiple myeloma, featuring Educational Updates from ASH 2012 ( Professor Gareth Morgan, Prof Roman Hajek, Dr María-Victoria Mateos, Prof Hartmut Goldschmidt )
8 Feb 2013

Clofarabine and other novel agents in AML; interview with Alan Burnett at ASH 2012

Prof Alan Burnett - Head of Haematology Department of Medical Genetics, Cardiff, Wales
Clofarabine and other novel agents in AML; interview with Alan Burnett at ASH 2012 ( Prof Alan Burnett - Head of Haematology Department of Medical Genetics, Cardiff, Wales )
16 Jan 2013

Advances in multiple myeloma from ASH 2012

Prof Thierry Facon - Centre Hospitalier Universitaire, France
Advances in multiple myeloma from ASH 2012 ( Prof Thierry Facon - Centre Hospitalier Universitaire, France )
20 Dec 2012

Expert overview of hot news in lymphoma from ASH 2012 (2/2)

Prof John Gribben, Prof Myron Czuczman, Prof Wolfram Brugger
Expert overview of hot news in lymphoma from ASH 2012 (2/2) ( Prof John Gribben, Prof Myron Czuczman, Prof Wolfram Brugger )
20 Dec 2012

Expert overview of hot news in lymphoma from ASH 2012 (1/2)

Prof John Gribben, Prof Myron Czuczman, Prof Wolfram Brugger
Expert overview of hot news in lymphoma from ASH 2012 (1/2) ( Prof John Gribben, Prof Myron Czuczman, Prof Wolfram Brugger )
20 Dec 2012

Advances in treatments for haematologic malignancies from the Sarah Cannon Research Institute presented at ASH 2012 (5/5)

Dr Ian Flinn - Sarah Cannon Research Institute, Nashville, USA
Advances in treatments for haematologic malignancies from the Sarah Cannon Research Institute presented at ASH 2012 (5/5) ( Dr Ian Flinn - Sarah Cannon Research Institute, Nashville, USA )
20 Dec 2012

Advances in treatments for haematologic malignancies from the Sarah Cannon Research Institute presented at ASH 2012 (4/5)

Dr Ian Flinn - Sarah Cannon Research Institute, Nashville, USA
Advances in treatments for haematologic malignancies from the Sarah Cannon Research Institute presented at ASH 2012 (4/5) ( Dr Ian Flinn - Sarah Cannon Research Institute, Nashville, USA )
20 Dec 2012

Advances in treatments for haematologic malignancies from the Sarah Cannon Research Institute presented at ASH 2012 (3/5)

Dr Ian Flinn - Sarah Cannon Research Institute, Nashville, USA
Advances in treatments for haematologic malignancies from the Sarah Cannon Research Institute presented at ASH 2012 (3/5) ( Dr Ian Flinn - Sarah Cannon Research Institute, Nashville, USA )
20 Dec 2012

Advances in treatments for haematologic malignancies from the Sarah Cannon Research Institute presented at ASH 2012 (2/5)

Dr Ian Flinn - Sarah Cannon Research Institute, Nashville, USA
Advances in treatments for haematologic malignancies from the Sarah Cannon Research Institute presented at ASH 2012 (2/5) ( Dr Ian Flinn - Sarah Cannon Research Institute, Nashville, USA )
20 Dec 2012

Advances in treatments for haematologic malignancies from the Sarah Cannon Research Institute presented at ASH 2012 (1/5)

Dr Ian Flinn - Sarah Cannon Research Institute, Nashville, USA
Advances in treatments for haematologic malignancies from the Sarah Cannon Research Institute presented at ASH 2012 (1/5) ( Dr Ian Flinn - Sarah Cannon Research Institute, Nashville, USA )
20 Dec 2012